A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.

This whitepaper explores how innovative chromatography solutions can improve aggregate removal while maintaining high product ...

A PAT roadmap should address data analysis, aggregation, visualization, and the smart utility of those data for greater process understanding.

Continuous manufacturing (CM) has become a contentious topic in the modern pharmaceutical lexicon, driven by divergent ...

The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic diseases, which is driving the need for biologics development ...

Saliva-based diagnostics have emerged as a transformative approach in medical testing, offering a non-invasive and efficient alternative to blood sampling. However, the complexity of saliva, which ...

The DNA-protein complex is then precipitated with an antibody that is specific to ... (4 μg), similarly subjected to size selection and purification of 250–300-bp fragments, served as the ...

RIP constitutes the second enzyme, along with caspase-8, that is a direct downstream mediator of Fas ... by adding 1 μg/ml of cross-linking antibodies to Flag (M2, Sigma, St. Louis, MO).

Reusing buffers in downstream operations would help biopharmaceutical manufacturers significantly reduce water consumption, making production more sustainable and cost efficient.